Comparison of effects of sugammadex administration timing on the success rate of neuromuscular function monitoring before endotracheal tube extubation and recovery profile in patients undergoing general anesthesia

Comparison of effects of sugammadex administration timing on success rate of neuromuscular function monitoring before extubation and recovery profile

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007899

Enrollment

Registered

2022-11-11

Start date

2022-12-22

Completion date

Unknown

Last updated

2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : After the end of surgery, the timing of administration of sugammadex, a neuromuscular block reversal agent, differs according to the group assigned by randomization. In the early

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for surgery under general anesthesia 2. American Society of Anesthesiologist Patient Status I~II (I is a normal healthy patient, II is patient with mild systemic disease). 3. 20 ~ 65 year old

Exclusion criteria

Exclusion criteria: - Contraindications to the use of sugammadex - Body mass index >30 kg/m2 - Neuromuscular disease - Moderate or severe liver, kidney, heart, or respiratory disease - Cognitive impairment

Design outcomes

Primary

Measure	Time frame
success rate of neuromuscular function monitoring	—

Secondary

Measure	Time frame
incidence of emergence agitation	—

Countries

Korea, Republic of

Contacts

Public ContactTae-Yun Sung

Konyang University Hospital

unt1231@naver.com+82-42-600-9316

Outcome results